These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16611100)

  • 21. Defective paracrine signalling by TGFbeta in yolk sac vasculature of endoglin mutant mice: a paradigm for hereditary haemorrhagic telangiectasia.
    Carvalho RL; Jonker L; Goumans MJ; Larsson J; Bouwman P; Karlsson S; Dijke PT; Arthur HM; Mummery CL
    Development; 2004 Dec; 131(24):6237-47. PubMed ID: 15548578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endoglin-mediated vascular remodeling: mechanisms underlying hereditary hemorrhagic telangiectasia.
    Lebrin F; Mummery CL
    Trends Cardiovasc Med; 2008 Jan; 18(1):25-32. PubMed ID: 18206806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deficiency in hereditary hemorrhagic telangiectasia-associated Endoglin elicits hypoxia-driven heart failure in zebrafish.
    Lelièvre E; Bureau C; Bordat Y; Frétaud M; Langevin C; Jopling C; Kissa K
    Dis Model Mech; 2023 May; 16(5):. PubMed ID: 37264878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ALK-1 mutations in liver transplanted patients with hereditary hemorrhagic telangiectasia.
    Argyriou L; Pfitzmann R; Wehner LE; Twelkemeyer S; Neuhaus P; Nayernia K; Engel W
    Liver Transpl; 2005 Sep; 11(9):1132-5. PubMed ID: 16123970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-205 is downregulated in hereditary hemorrhagic telangiectasia and impairs TGF-beta signaling pathways in endothelial cells.
    Tabruyn SP; Hansen S; Ojeda-Fernández ML; Bovy N; Zarrabeitia R; Recio-Poveda L; Bernabéu C; Martial JA; Botella LM; Struman I
    Angiogenesis; 2013 Oct; 16(4):877-87. PubMed ID: 23800974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered endothelial gene expression associated with hereditary haemorrhagic telangiectasia.
    Thomas B; Eyries M; Montagne K; Martin S; Agrapart M; Simerman-François R; Letarte M; Soubrier F
    Eur J Clin Invest; 2007 Jul; 37(7):580-8. PubMed ID: 17576210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced endothelial secretion and plasma levels of transforming growth factor-beta1 in patients with hereditary hemorrhagic telangiectasia type 1.
    Letarte M; McDonald ML; Li C; Kathirkamathamby K; Vera S; Pece-Barbara N; Kumar S
    Cardiovasc Res; 2005 Oct; 68(1):155-64. PubMed ID: 15907823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two common endoglin mutations in families with hereditary hemorrhagic telangiectasia in the Netherlands Antilles: evidence for a founder effect.
    Gallione CJ; Scheessele EA; Reinhardt D; Duits AJ; Berg JN; Westermann CJ; Marchuk DA
    Hum Genet; 2000 Jul; 107(1):40-4. PubMed ID: 10982033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bazedoxifene, a new orphan drug for the treatment of bleeding in hereditary haemorrhagic telangiectasia.
    Zarrabeitia R; Ojeda-Fernandez L; Recio L; Bernabéu C; Parra JA; Albiñana V; Botella LM
    Thromb Haemost; 2016 Jun; 115(6):1167-77. PubMed ID: 26818701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Analysis of angiogenesis related proteins and its implication in type-2 hereditary hemorrhagic telangiectasia].
    Peng HL; Hu GY; Zhang GS; Gong FJ
    Zhonghua Xue Ye Xue Za Zhi; 2006 Sep; 27(9):616-20. PubMed ID: 17278429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pericytes in Hereditary Hemorrhagic Telangiectasia.
    Galaris G; Thalgott JH; Lebrin FPG
    Adv Exp Med Biol; 2019; 1147():215-246. PubMed ID: 31147880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutation affecting the proximal promoter of Endoglin as the origin of hereditary hemorrhagic telangiectasia type 1.
    Albiñana V; Zafra MP; Colau J; Zarrabeitia R; Recio-Poveda L; Olavarrieta L; Pérez-Pérez J; Botella LM
    BMC Med Genet; 2017 Feb; 18(1):20. PubMed ID: 28231770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Rendu-Osler disease: clinical and molecular update].
    Bailly S; Dupuis-Girod S; Plauchu H
    Med Sci (Paris); 2010 Oct; 26(10):855-60. PubMed ID: 20929677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel missense and frameshift mutations in the activin receptor-like kinase-1 gene in hereditary hemorrhagic telangiectasia. Mutations in brief no. 164. Online.
    Klaus DJ; Gallione CJ; Anthony K; Yeh EY; Yu J; Lux A; Johnson DW; Marchuk DA
    Hum Mutat; 1998; 12(2):137. PubMed ID: 10694922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunological abnormalities associated with hereditary haemorrhagic telangiectasia.
    Guilhem A; Malcus C; Clarivet B; Plauchu H; Dupuis-Girod S
    J Intern Med; 2013 Oct; 274(4):351-62. PubMed ID: 23772771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia.
    Harrison RE; Flanagan JA; Sankelo M; Abdalla SA; Rowell J; Machado RD; Elliott CG; Robbins IM; Olschewski H; McLaughlin V; Gruenig E; Kermeen F; Halme M; Räisänen-Sokolowski A; Laitinen T; Morrell NW; Trembath RC
    J Med Genet; 2003 Dec; 40(12):865-71. PubMed ID: 14684682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of a significant association between mutations in the ACVRL1 gene and hepatic involvement in German patients with hereditary haemorrhagic telangiectasia.
    Brakensiek K; Frye-Boukhriss H; Mälzer M; Abramowicz M; Bahr MJ; von Beckerath N; Bergmann C; Caselitz M; Holinski-Feder E; Muschke P; Oexle K; Strobl-Wildemann G; Wolff G; El-Harith EA; Stuhrmann M
    Clin Genet; 2008 Aug; 74(2):171-7. PubMed ID: 18498373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hereditary hemorrhagic telangiectasia.
    Nguyen NQ
    Dermatol Online J; 2005 Dec; 11(4):19. PubMed ID: 16403391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogen therapy for hereditary haemorrhagic telangiectasia (HHT): Effects of raloxifene, on Endoglin and ALK1 expression in endothelial cells.
    Albiñana V; Bernabeu-Herrero ME; Zarrabeitia R; Bernabéu C; Botella LM
    Thromb Haemost; 2010 Mar; 103(3):525-34. PubMed ID: 20135064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Liver involvement in hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease). Report of one case and review of the literature].
    Proux A; Tapiero S; Girszyn N; Levesque H; Marie I
    Rev Med Interne; 2007 Nov; 28(11):775-9. PubMed ID: 17624637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.